[Therapeutic effect of matrix metalloproteinase inhibitor (R-94138) for peritoneal metastasis of stomach neoplasm models].
Igarashi
N
N
Kubota
T
T
Otani
Y
Y
Watanabe
M
M
Kitajima
M
M
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002945:Cisplatin / Q000008:administration & dosage; D004195:Disease Models, Animal; D007274:Injections, Intraperitoneal; D008297:Male; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors*; D051379:Mice; D008807:Mice, Inbred BALB C; D016685:Mitomycin / Q000008:administration & dosage; D009362:Neoplasm Metastasis; D010529:Peritoneal Cavity / Q000473:pathology*; D011480:Protease Inhibitors / Q000627:therapeutic use*; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000473:pathology
D011480:Protease Inhibitors; D016685:Mitomycin; D008666:Metalloendopeptidases; D002945:Cisplatin